Showing results (61-70 of 224) with videos related to

Sort By:
Pageof 23
Arthritis and Rheumatism|February 2, 2008
AUF1, the regulator of tumor necrosis factor alpha messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseasesKarl Skriner, Wolfgang Hueber, Erhan Süleymanoglu, et al.
Arthritis and Rheumatism|April 3, 2008
Comparison of employability outcomes among patients with early or long-standing rheumatoid arthritisChenglong Han, Josef Smolen, Arthur Kavanaugh, et al.
Arthritis and Rheumatism|January 1, 2009
Identification of relevant concepts of functioning in daily life in people with systemic lupus erythematosus: A patient Delphi exerciseBettina Bauernfeind, Martin Aringer, Birgit Prodinger, et al.
Arthritis and Rheumatism|February 12, 2004
Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trialEdward C Keystone, Michael H Schiff, Joel M Kremer, et al.
The Journal of Rheumatology|November 17, 2010
Factors associated with radiographic progression in patients with rheumatoid arthritis who were treated with methotrexateMichael E Weinblatt, Edward C Keystone, Marc D Cohen, et al.
Arthritis Research & Therapy|January 12, 2005
p53 tumor suppressor gene mutations in fibroblast-like synoviocytes from erosion synovium and non-erosion synovium in rheumatoid arthritisYuji Yamanishi, David L Boyle, Douglas R Green, et al.
The Journal of Rheumatology|September 3, 2011
Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogressionAlvin F Wells, Rene Westhovens, Diane Moniz Reed, et al.
Arthritis Research & Therapy|November 12, 2019
Disease activity improvements with optimal discriminatory ability between treatment arms: applicability in early and established rheumatoid arthritis clinical trialsJosef Smolen, Roy Fleischmann, Daniel Aletaha, et al.
Arthritis and Rheumatism|July 13, 2002
The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trialE William St Clair, Carrie L Wagner, Adedigbo A Fasanmade, et al.
Rheumatology (Oxford, England)|September 13, 2015
Two-year radiographic and clinical outcomes from the Canadian Methotrexate and Etanercept Outcome study in patients with rheumatoid arthritisEdward C Keystone, Janet E Pope, J Carter Thorne, et al.
Pageof 23